KYNB
KYNTRA BIO, INC.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$5.28
+8.87%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.09x
- PEG TTM
- —
- Price / book
- -0.71x
- Price / sales
- 4.63x
- Price / cash flow
- -0.56x
Enterprise value
- Enterprise value
- -$47.9M
- EV / sales
- -10.38x
- EV / EBITDA
- 0.51x
- EV / EBIT
- 0.94x
- Market cap
- $21.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026